Schwab Charitable Fund Amgen Inc Transaction History

Schwab Charitable Fund

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 14, 2021	SELL	$212.27 - $248.7 $322,650 - $378,024	-1,520 Closed	0 $0
Q4 2020 Feb 02, 2021	SELL	$216.38 - $257.67 $1,081 - $1,288	-5 Reduced 0.33%	1,520 $349,000
Q2 2020 Oct 20, 2020	SELL	$197.81 - $242.74 $51,430 - $63,112	-260 Reduced 14.57%	1,525 $360,000
Q1 2020 Apr 14, 2020	BUY	$182.24 - $241.7 $51,938 - $68,884	285 Added 19.0%	1,785 $362,000
Q4 2019 Jan 15, 2020	BUY	$189.21 - $243.2 $57,709 - $74,176	305 Added 25.52%	1,500 $362,000
Q3 2019 Oct 16, 2019	BUY	$174.11 - $208.62 $16,540 - $19,818	95 Added 8.64%	1,195 $231,000
Q2 2019 Jul 10, 2019	BUY	$166.7 - $195.41 $183,370 - $214,951	1,100 New	1,100 $203,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Schwab Charitable Fund, based on Form 13F filings with the SEC.

Stay updated on Schwab Charitable Fund with notifications on news.